CaineM., RazS., ZeiglerM.: Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Brit. J. Urol., 47; 193 (1975).
2.
HutchJ. A., RamboO. M. J.: A study of the anatomy of the prostate, prostatic urethra and the urinary sphincter system. J. Urol., 104; 443–452 (1970).
3.
McGregorR. J., DioknoA. C.: The alpha-adrenergic blocking action of Prazosin hydrochloride on the canine urethra. Invest. Urol., 18; n. 6 (1981).
4.
ShapiroA., MazourB., CaineM.: The alpha-adrenergic blocking effect of Prazosin on the human prostate. Urol. Res., 9; 17–20 (1981).
5.
AnderssonK. E., HedlundA. E. K. H., MattiassonA.: Effects of Prazosin on isolated human urethra and in patients with lower motor neuron lesions. Invest. Urol., 19; n. 1 (1981).
6.
CastroG. E.: Prostatic hypertrophy and neoplasia. In: GellerJ.: Medical treatment of benign prostatic hypertrophy.M. P. T., Lancaster1974.
7.
KanekoS., MinamiK., VachikuS., KuritaT.: The effect of the alpha-adrenergic blocking agent phentolamine on bladder neck disfunction and a fluorescent histochemical study of bladder neck smooth muscle. Invest. Urol., 18; n. 3 (1980).
8.
CaineM., PerlbergS., MeretykS.: A placebo controlled doubleblind study of the effect of phcnoxybenzamine in benign prostatic obstruction. Brit. J. Urol., 50; 551 (1978).
9.
GerstemberT., BlaabyergJ., LykkegaardN. M., ClausenS.: Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodynamic investigation. Invest. Urol., 18; 29 (1980).
10.
CaineM.: The importance of adrenergic receptors in disordes of micturiction. Eur. Urol., 3; 1–6 (1977).
11.
JensenD.: Uninibited neurogenic bladder treated with Prazosin. Scand. J. Urol. & Nephrol., 15; 229–233 (1981).
12.
PhillipsS. J., RichensA., ShandD. G.: Adrenergic control of tendom reflexes in man. Brit. J Pharmacol., 47; 595 (1973).
13.
MajJ.: Depression of spasticity by alpha-adrenergic blockade. Acta Neurol. Scand., 57; 65 (1978).
14.
ThienTh., DelaereK. P. J., DebrujneF. M. J., KoeneR. A. P.: Urinary incontinence caused by Prazosin. Brit. J. Med., 1; 622 (1978).
